BACKGROUND: Therapy for management of acute myocardial infarction (AMI) varies according to patient, prescriber and geo-graphical characteristics. OBJECTIVES: To describe the in-hospital use of reperfusion therapy for ST elevation MI (STEMI) and discharge use of acetylsalicylic acid, beta-blockers, angiotensin-converting enzyme inhibitors (ACEIs) and statins in patients presenting with either STEMI o
To evaluate significance of different reperfusion methods in the treatment of acute ST segment eleva...
Over the past five decades, management of acute ST-segment elevation myocardial infarction (STEMI) h...
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. Timely repe...
BACKGROUND: Therapy for management of acute myocardial infarction (AMI) varies according to patient,...
<p>ACEI, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; CABG, corona...
Acute myocardial infarction (AMI) occurs when there is acute disruption of coronary blood flow, resu...
Acute myocardial infarction (AMI) is a serious and potentially lethal condition for which percutaneo...
Introduction: Myocardial infarction is a major cause of death and disability worldwide. American Col...
This editorial refers to ‘Long-term clinical outcomes after rescue angioplasty are not different fro...
Background. The prognosis for patients after acute myocardial infarction (AMI) can be improved by pr...
peer reviewedAcute myocardial infarction (AMI) is a serious condition which requires rapid hospital ...
Background: Early drug therapy in patients with ST-elevation infarction is essential for improved sh...
Acute MI is the main reason damaging the myocardium and a potentially life-threatening situation. Th...
Medical discharge management of acute coronary syndromes (ACS) remains suboptimal outside randomised...
Aims: The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous Coronary Interv...
To evaluate significance of different reperfusion methods in the treatment of acute ST segment eleva...
Over the past five decades, management of acute ST-segment elevation myocardial infarction (STEMI) h...
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. Timely repe...
BACKGROUND: Therapy for management of acute myocardial infarction (AMI) varies according to patient,...
<p>ACEI, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; CABG, corona...
Acute myocardial infarction (AMI) occurs when there is acute disruption of coronary blood flow, resu...
Acute myocardial infarction (AMI) is a serious and potentially lethal condition for which percutaneo...
Introduction: Myocardial infarction is a major cause of death and disability worldwide. American Col...
This editorial refers to ‘Long-term clinical outcomes after rescue angioplasty are not different fro...
Background. The prognosis for patients after acute myocardial infarction (AMI) can be improved by pr...
peer reviewedAcute myocardial infarction (AMI) is a serious condition which requires rapid hospital ...
Background: Early drug therapy in patients with ST-elevation infarction is essential for improved sh...
Acute MI is the main reason damaging the myocardium and a potentially life-threatening situation. Th...
Medical discharge management of acute coronary syndromes (ACS) remains suboptimal outside randomised...
Aims: The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous Coronary Interv...
To evaluate significance of different reperfusion methods in the treatment of acute ST segment eleva...
Over the past five decades, management of acute ST-segment elevation myocardial infarction (STEMI) h...
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. Timely repe...